Zilovertamab vedotin |
VLS-101; MK-2140 |
Phase 3 Clinical |
Oncternal Therapeutics Inc, University Of California San Diego |
Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Waldenstrom Macroglobulinemia; Burkitt Lymphoma; Lymphoma, T-Cell; Leukemia, Myeloid, Acute; Richter's Syndrome; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, B-Cell; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Stomach Neoplasms; Lymphoma, B-Cell, Marginal Zone; Ovarian Neoplasms; Hematologic Neoplasms |
Details
|
Zilovertamab |
UC-961 |
Phase 2 Clinical |
University Of California San Diego, Oncternal Therapeutics Inc |
Lymphoma, B-Cell, Marginal Zone; Lymphoma, B-Cell; Immunoproliferative Disorders; Lymphatic Diseases; Immune System Diseases; Prostatic Neoplasms, Castration-Resistant; Lymphoma, Mantle-Cell; Breast Neoplasms; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
ONCT-808 |
ONCT-808 |
Phase 2 Clinical |
Oncternal Therapeutics Inc |
Lymphoma, B-Cell; Neoplasms |
Details
|
Nebratamig |
GNC-035 |
Phase 2 Clinical |
|
Solid tumours; Hematologic Neoplasms; Breast Neoplasms; Metastatic breast cancer; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
HG-030 |
HG-030 |
Phase 1 Clinical |
Hitgen Inc |
Solid tumours |
Details
|
EMB-07 |
EMB-07 |
Phase 1 Clinical |
Shanghai Epimab Biotherapeutics, Inc |
Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Adenocarcinoma of Lung; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Lymphoma; Uterine Neoplasms; Neoplasm Metastasis |
Details
|
PB-004 |
PB004; PBA-0405; PB004 PureBIKE; PB-004 |
Phase 1 Clinical |
Pure Biologics SA |
Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Sarcoma |
Details
|
PRGN-3007 |
PRGN-3007 |
Phase 1 Clinical |
Precigen Inc |
Hematologic Neoplasms; Solid tumours; Lymphoma, Large B-Cell, Diffuse; Triple Negative Breast Neoplasms; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
LYL-797 |
LYL-797 |
Phase 1 Clinical |
Lyell Immunopharma Inc |
Solid tumours; Triple Negative Breast Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
NVG-111 |
NVG-111 |
Phase 1 Clinical |
NovalGen Ltd |
Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Melanoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
LCB-71 |
CS-5001; LCB-71; ABL-202 |
Phase 1 Clinical |
Legochem Biosciences Inc, Abl Bio Inc |
Solid tumours; Lymphoma, B-Cell; Hematologic Neoplasms; Lymphoma |
Details
|
SIM-201 |
SIM-201; SIM-0201 |
Phase 1 Clinical |
Jiangsu Simcere Pharmaceutical Co Ltd |
Solid tumours |
Details
|
Zilovertamab vedotin |
VLS-101; MK-2140 |
Phase 3 Clinical |
Oncternal Therapeutics Inc, University Of California San Diego |
Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Waldenstrom Macroglobulinemia; Burkitt Lymphoma; Lymphoma, T-Cell; Leukemia, Myeloid, Acute; Richter's Syndrome; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, B-Cell; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Pancreatic Neoplasms; Stomach Neoplasms; Lymphoma, B-Cell, Marginal Zone; Ovarian Neoplasms; Hematologic Neoplasms |
Details
|
Zilovertamab |
UC-961 |
Phase 2 Clinical |
University Of California San Diego, Oncternal Therapeutics Inc |
Lymphoma, B-Cell, Marginal Zone; Lymphoma, B-Cell; Immunoproliferative Disorders; Lymphatic Diseases; Immune System Diseases; Prostatic Neoplasms, Castration-Resistant; Lymphoma, Mantle-Cell; Breast Neoplasms; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
ONCT-808 |
ONCT-808 |
Phase 2 Clinical |
Oncternal Therapeutics Inc |
Lymphoma, B-Cell; Neoplasms |
Details
|
Nebratamig |
GNC-035 |
Phase 2 Clinical |
|
Solid tumours; Hematologic Neoplasms; Breast Neoplasms; Metastatic breast cancer; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
HG-030 |
HG-030 |
Phase 1 Clinical |
Hitgen Inc |
Solid tumours |
Details
|
EMB-07 |
EMB-07 |
Phase 1 Clinical |
Shanghai Epimab Biotherapeutics, Inc |
Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Adenocarcinoma of Lung; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Lymphoma; Uterine Neoplasms; Neoplasm Metastasis |
Details
|
PB-004 |
PB004; PBA-0405; PB004 PureBIKE; PB-004 |
Phase 1 Clinical |
Pure Biologics SA |
Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Sarcoma |
Details
|
PRGN-3007 |
PRGN-3007 |
Phase 1 Clinical |
Precigen Inc |
Hematologic Neoplasms; Solid tumours; Lymphoma, Large B-Cell, Diffuse; Triple Negative Breast Neoplasms; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
LYL-797 |
LYL-797 |
Phase 1 Clinical |
Lyell Immunopharma Inc |
Solid tumours; Triple Negative Breast Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
NVG-111 |
NVG-111 |
Phase 1 Clinical |
NovalGen Ltd |
Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Melanoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
LCB-71 |
CS-5001; LCB-71; ABL-202 |
Phase 1 Clinical |
Legochem Biosciences Inc, Abl Bio Inc |
Solid tumours; Lymphoma, B-Cell; Hematologic Neoplasms; Lymphoma |
Details
|
SIM-201 |
SIM-201; SIM-0201 |
Phase 1 Clinical |
Jiangsu Simcere Pharmaceutical Co Ltd |
Solid tumours |
Details
|